Matthew Hamilton Rosenberg’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$729K Buy
5,672
+542
+11% +$63.4K 0.14% 76
2026
Q1
$617K Buy
5,130
+247
+5% +$28.5K 0.13% 74
2025
Q4
$514K Sell
4,883
-110
-2% -$10.3K 0.11% 87
2025
Q3
$419K Sell
4,993
-40
-0.8% -$3.29K 0.09% 105
2025
Q2
$398K Buy
5,033
+1,349
+37% +$107K 0.09% 107
2025
Q1
$331K Buy
3,684
+469
+15% +$43.8K 0.08% 110
2024
Q4
$320K Sell
3,215
-375
-10% -$38.7K 0.08% 118
2024
Q3
$408K Buy
3,590
+161
+5% +$19.1K 0.11% 88
2024
Q2
$439K Buy
3,429
+338
+11% +$43.5K 0.13% 76
2024
Q1
$405K Sell
3,091
-254
-8% -$31.3K 0.12% 87
2023
Q4
$365K Buy
3,345
+59
+2% +$6.12K 0.11% 94
2023
Q3
$338K Sell
3,286
-378
-10% -$40.7K 0.11% 93
2023
Q2
$423K Sell
3,664
-446
-11% -$50.6K 0.14% 74
2023
Q1
$437K Buy
4,110
+1
+0% +$108 0.14% 77
2022
Q4
$456K Buy
4,109
+74
+2% +$7.56K 0.15% 74
2022
Q3
$347K Buy
4,035
+424
+12% +$37.9K 0.13% 96
2022
Q2
$334K Buy
3,611
+328
+10% +$29.1K 0.13% 102
2022
Q1
$269K Buy
3,283
+682
+26% +$53.8K 0.09% 138
2021
Q4
$199K Sell
2,601
-224
-8% -$17.8K 0.07% 185
2021
Q3
$212K Buy
2,825
+711
+34% +$54.1K 0.08% 155
2021
Q2
$164K Sell
2,114
-49
-2% -$3.65K 0.09% 170
2021
Q1
$159K Buy
2,163
+117
+6% +$8.63K 0.09% 157
2020
Q4
$160K Buy
2,046
+409
+25% +$31.3K 0.1% 143
2020
Q3
$130K Buy
1,637
+133
+9% +$10.4K 0.1% 144
2020
Q2
$111K Buy
1,504
+120
+9% +$9.03K 0.09% 165
2020
Q1
$102K Buy
+1,384
New +$109K 0.1% 117

Other funds holding MRK

Matthew Hamilton Rosenberg's MRK Position: Q2 2026 in Review

Matthew Hamilton Rosenberg increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $63.4K and bringing the position to 5,672 shares worth $729K. The position accounts for 0.14% of the portfolio, ranked #76.

Matthew Hamilton Rosenberg first reported a position in MRK in Q1 2020 and has held it in 26 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Matthew Hamilton Rosenberg held 5,672 shares of Merck worth $729K as of Q2 2026.
  • Matthew Hamilton Rosenberg bought 542 Merck shares in Q2 2026, an estimated $63.4K.
  • Merck made up 0.14% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #76 holding.
  • Matthew Hamilton Rosenberg first reported a position in Merck in Q1 2020 and has held it in 26 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.